300143.SZ Overview

Company Profile

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Qingdao, China.

Related stocks

2697.HK

2697.HK • China

183 HKD

1.2B USD

600587.SS

600587.SS • China

SHINVA MEDICAL INSTRUMENT CO LT

13.12 CNY

1.19B USD 1Y -19.8%

600055.SS

600055.SS • China

BEIJING WANDONG MEDICAL TECHNOL

10.48 CNY

1.1B USD 1Y -41.3%

2675.HK

2675.HK • China

33 HKD

1.64B USD

0853.HK

0853.HK • China

6.08 HKD

1.48B USD 1Y -59%

688575.SS

688575.SS • China

SHENZHEN YHLO BIOTECH CO LTD

10.46 CNY

894.36M USD 1Y -28.1%

688626.SS

688626.SS • China

XIANGYU MEDICAL CO LTD

40.49 CNY

969.39M USD 1Y -22.7%

2190.HK

2190.HK • China

20.5 HKD

861.68M USD 1Y -17.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Medical Devices

Website

https://www.inkonlife.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

44.1% p.a.

Max Drawdown (5Y)

-60.5%

Sharpe Ratio (5Y)

-0.22

Beta Factor

0.27

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 99.4 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.1% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -76.8% in the extended horizon.